Companies House · 03362860

TAKEDA UK LIMITED

UK registered company, private limited company, incorporated 25 Apr 1997.

Active
50
Public contracts
0
Spend payments
Total spend

TAKEDA UK LIMITED is a UK company registered at Companies House under number 03362860. This page links its registry record to its activity in UK public procurement — the contracts it has been awarded and the transparency-spend payments recorded against it.

Companies House record

Company number
03362860
Status
Active
Company type
Private Limited Company
Incorporated
25 Apr 1997
Country of origin
United Kingdom
Registered office
1 KINGDOM STREET, LONDON, W2 6BD, UNITED KINGDOM
Nature of business (SIC)
46460 - Wholesale of pharmaceutical goods
Accounts category
FULL
View source on data.gov.uk

Public sector contracts

Contract awards linked to TAKEDA UK LIMITED.

ProcurementBuyerAwardedValue
NHS South of England Branded Medicines - Tranche A - September 2023NHS England
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
NHS Framework Agreement for Branded Medicines – NationalNHS England
NHS National Generic Pharmaceuticals Wave 13The NHS Commissioning Board (operating under the name of NHS England)
NHS Framework for the Midlands and East, Branded Medicines – Tranche A and Annual TrancheThe NHS Commissioning Board (operating under the name of NHS England)
Invitation to offer for NHS Framework for the North of England, Branded Medicines – Tranche B, Annual Tranche and Insulin Aspart Biosimilar (Trurapi®)The NHS Commissioning Board (operating under the name of NHS England)
Invitation to offer for NHS Framework for the North of England, Branded Medicines – Tranche B, Annual Tranche and Insulin Aspart Biosimilar (Trurapi®)The NHS Commissioning Board (operating under the name of NHS England)
NHS Framework Agreement for Branded Medicines - National TenderNHS England
NHS National Pharmaceuticals Transition 2022_2NHS England
NHS National Generic Pharmaceuticals Wave 14bNHS England
NHS National Generic Pharmaceuticals Wave 14bNHS England
NHS National Generic Pharmaceuticals Wave 14bNHS England
NHS National Generic Pharmaceuticals Wave 14bNHS England
NHS National Generic Pharmaceuticals Wave 14cNHS England
NHS National Proprietary Category Tender - 1 May 2024NHS England
NHS National Generic Pharmaceuticals Wave 15aNHS England
Invitation to offer for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 01 May 2025NHS England
Medicinal Products and Pharma Funded Homecare ServicesProcurement and Logistics Service
Gastro Intestinal, Endocrine, Nutrition & Blood Generic MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
ERT MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
NP92619 ERT MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
NP39823 Gastro Intestinal, Endocrine, Nutrition & Blood MedicineThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia BNHS England
NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia BNHS England
NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia BNHS England
NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia BNHS England
NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia BNHS England
NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia BNHS England
NHS National Framework Agreement for the supply of products for the management of Hereditary AngioedemaNHS England
NHS National Framework Agreement for the supply of products for the management of Hereditary AngioedemaNHS England
NHS National Framework Agreement for the supply of products for the management of Hereditary AngioedemaNHS England
NHS National Framework Agreement for the supply of products for the management of Hereditary AngioedemaNHS England
Proprietary DrugsVelindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)
Proprietary DrugseTenderwales
Invitation to offer for NHS London Branded Medicines - Tranche A and AnnualNHS England
NHS South of England Branded Medicines - Tranche B and AnnualNHS England
NHS South of England Branded Medicines - Tranche B and AnnualNHS England
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.The NHS Commissioning Board (operating under the name of NHS England)
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.The NHS Commissioning Board (operating under the name of NHS England)
Medicinal Products Dynamic Purchasing System (131864)Regional Business Services Organisation, Procurement and Logistics Service
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024NHS England
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024NHS England
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024NHS England
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024NHS England
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024NHS England
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024NHS England
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024NHS England

Supplier identities

How this company appears as a supplier across the data.

FAQs about TAKEDA UK LIMITED

Is TAKEDA UK LIMITED an active company?

TAKEDA UK LIMITED (company number 03362860) is recorded as "Active", incorporated on 25 Apr 1997.

What does TAKEDA UK LIMITED do?

Its Companies House nature-of-business (SIC) is: 46460 - Wholesale of pharmaceutical goods.

Has TAKEDA UK LIMITED won UK public-sector contracts?

Yes — 50 public-sector contract awards are linked to this company in our data.

Where is TAKEDA UK LIMITED based?

Its registered office is 1 KINGDOM STREET, LONDON, W2 6BD, UNITED KINGDOM.

Understand any company's public-sector footprint

Enable links Companies House to live procurement and spend data — see contracts, buyers and payments for any UK supplier.

Get in touch with Enable